CAMBRIDGE, Massachusetts, June 6 -- The Massachusetts Biotechnology Council issued the following statement on June 4, 2026, by CEO Kendalle Burlin O'Connell:

* * *

CEO Innovation Policy Update 06.04.26

A busy week in Washington with real consequences for Massachusetts -from new legislation putting biotech licensing deals under national security review, to a sweeping OMB proposal that would hand political appointees veto power over scientific peer revie . . .

Click here for more information about our products